| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Metacrine, Inc. | Chief Business Officer | Common Stock | 103K | $48.6K | $0.47 | 26 Jan 2023 | Direct |
| PhaseBio Pharmaceuticals Inc | VP, Corporate Development | Common Stock | 7.06K | 20 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MTCR | Metacrine, Inc. | 26 Jan 2023 | 1 | -$44.3K | 4 | Chief Business Officer | 27 Jan 2023, 15:44 |
| MTCR | Metacrine, Inc. | 27 Feb 2022 | 2 | $0 | 4 | Chief Business Officer | 01 Mar 2022, 15:55 |
| MTCR | Metacrine, Inc. | 18 Feb 2022 | 0 | $0 | 3 | Chief Business Officer | 24 Feb 2022, 15:52 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 20 May 2021 | 1 | $8.11K | 4 | VP, Corporate Development | 24 May 2021, 18:10 |